StockrabitBrowse analysts
Analyst questions

Umang Ghada

Avener Capital
ONESOURCE

Onesource Specialty Pharma Limited

All company calls
Onesource Specialty Pharma Limited CC-Mar25.pdf
6 May 2025
Open call
  1. Hi, sir. Thank you for taking my question and congratulations on a great set of numbers. So, my question was again, slightly on the demand side, which the last participant asked. There, you know, a lot of new therapies are coming for weight loss. And a lot of oral drugs are also gaining traction in GLP for weight loss and diabetes as well.

    Read in transcript
  2. Understood. So, like, we don't see any demand challenges as such, in terms of our visibility. So, a very small update, I would require that, you know, that the capacity that you are adding, the 220 million which are planning to go, all of this is planned to be added in India, or some capacity is to be planned outside of India as well, like, in terms of location?

    Read in transcript